Integration of deep learning with multiparametric MRI has enabled precise prediction of perineural invasion in prostate cancer, advancing oncological imaging. Meanwhile, acquisition of Paige digital pathology firm by Tempus AI for $81 million signals consolidation of AI-driven cancer diagnostics. These strides promise enhanced personalized treatment.